378 related articles for article (PubMed ID: 24931325)
21. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
Rostas SE; McPherson C
Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
[TBL] [Abstract][Full Text] [Related]
22. Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia.
McNamara DG; Nixon GM; Anderson BJ
Paediatr Anaesth; 2004 Jul; 14(7):541-50. PubMed ID: 15200650
[No Abstract] [Full Text] [Related]
23. Caffeine for apnea of prematurity.
Hand IL; Noble LM
N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
[No Abstract] [Full Text] [Related]
24. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
[TBL] [Abstract][Full Text] [Related]
25. Theophylline or caffeine: which is best for apnea of prematurity?
Gannon BA
Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
[TBL] [Abstract][Full Text] [Related]
26. On the caffeination of prematurity.
Stevenson DK
N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
[No Abstract] [Full Text] [Related]
27. Evidence-based methylxanthine use in the NICU.
Spitzer AR
Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
[TBL] [Abstract][Full Text] [Related]
28. Methylxanthines in apnea of prematurity.
Aranda JV; Turmen T
Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
[TBL] [Abstract][Full Text] [Related]
29. Caffeine for apnea of prematurity.
Coulter DM
N Engl J Med; 2006 Aug; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
[No Abstract] [Full Text] [Related]
30. Apnea of prematurity: theophylline v. caffeine.
Harrison H
Alaska Med; 1992; 34(4):173-6. PubMed ID: 1288312
[TBL] [Abstract][Full Text] [Related]
31. Neurodevelopmental outcomes after neonatal caffeine therapy.
Synnes A; Grunau RE
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
[TBL] [Abstract][Full Text] [Related]
32. Developmental aspects of percutaneous caffeine absorption in premature infants.
Amato M; Hüppi P; Isenschmid M; Schneider H
Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150
[TBL] [Abstract][Full Text] [Related]
33. [Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units].
Bénard M; Boutroy MJ; Glorieux I; Casper C
Arch Pediatr; 2005 Feb; 12(2):151-5. PubMed ID: 15694538
[TBL] [Abstract][Full Text] [Related]
34. Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
Schmidt B; Roberts RS; Davis P; Doyle LW;
Arch Dis Child; 2011 Aug; 96(8):784. PubMed ID: 21377992
[No Abstract] [Full Text] [Related]
35. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
Winckworth LC; Powell E
Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
[No Abstract] [Full Text] [Related]
36. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
Marcus CL; Meltzer LJ; Roberts RS; Traylor J; Dix J; D'ilario J; Asztalos E; Opie G; Doyle LW; Biggs SN; Nixon GM; Narang I; Bhattacharjee R; Davey M; Horne RS; Cheshire M; Gibbons J; Costantini L; Bradford R; Schmidt B;
Am J Respir Crit Care Med; 2014 Oct; 190(7):791-9. PubMed ID: 25171195
[TBL] [Abstract][Full Text] [Related]
37. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.
Davis PG; Schmidt B; Roberts RS; Doyle LW; Asztalos E; Haslam R; Sinha S; Tin W;
J Pediatr; 2010 Mar; 156(3):382-7. PubMed ID: 19926098
[TBL] [Abstract][Full Text] [Related]
38. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea.
Bauer J; Maier K; Linderkamp O; Hentschel R
Pediatrics; 2001 Apr; 107(4):660-3. PubMed ID: 11335740
[TBL] [Abstract][Full Text] [Related]
39. Current management of apnea in premature infants: is caffeine the magic bullet?
Bancalari E
Early Hum Dev; 2014 Sep; 90 Suppl 2():S1-2. PubMed ID: 25220117
[No Abstract] [Full Text] [Related]
40. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
